Drug recall · September 9, 2026
Buprenorphine Sublingual Tablets recall
Why: Labeling: Label Mix-up
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
- Lots / codes
Lot # 1030023, Exp Date: 06/30/2027.
- Quantity
- 10,953 cartons.
- Company
- American Health Packaging, Columbus, OH
- Distribution
- US Nationwide.
- Initiated
- August 19, 2026 · Voluntary: Firm initiated
- Classified
- September 14, 2026
- Reported
- September 9, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Buprenorphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.